Literature DB >> 22529087

Incomplete avulsion of the proximal insertion of the hamstring: outcome two years following surgical repair.

S E Aldridge1, G N A Heilpern, J R Carmichael, A P Sprowson, D G Wood.   

Abstract

Incomplete avulsion of the proximal hamstrings can be a severely debilitating injury that causes weakness, pain while sitting and inability to run. The results of the surgical treatment of 23 consecutive patients with such injuries at least two years after surgery are described. The surgery consisted of the repair of the hamstrings directly onto the ischial tuberosity. At review, using a visual analogue scale (VAS, 0 to 100), pain while sitting improved from a mean of 40 (0 to 100) to 64 (0 to 100) (p = 0.024), weakness from a mean of 39 (0 to 90) to 76 (7 to 100) (p = 0.0001) and the ability to run from a mean of 24 (0 to 88) to 64 (0 to 95) (p = 0.0001). According to a VAS, satisfaction was rated at a mean of 81 (0 to 100) and 20 patients (87%) would have the same procedure again. Hamstring strength measured pre- and post-operatively had improved significantly from a mean of 64% (0% to 95%) to 88% (50% to 114%) compared with the normal side. Most of these patients with symptomatic incomplete hamstring avulsions unresponsive to conservative treatment had an improved outcome after surgical repair.

Entities:  

Mesh:

Year:  2012        PMID: 22529087     DOI: 10.1302/0301-620X.94B5.28043

Source DB:  PubMed          Journal:  J Bone Joint Surg Br        ISSN: 0301-620X


  14 in total

1.  The prevalence of proximal hamstring pathology on MRI in the asymptomatic population.

Authors:  S M Thompson; S Fung; D G Wood
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-08-04       Impact factor: 4.342

2.  Endoscopic transtendinous repair for partial-thickness proximal hamstring tendon tears.

Authors:  Timothy J Jackson; Anthony Trenga; Dror Lindner; Youseff El-Bitar; Benjamin G Domb
Journal:  Arthrosc Tech       Date:  2014-01-31

3.  Gross anatomical and dimensional characteristics of the proximal hamstring origin.

Authors:  Matthias J Feucht; Johannes E Plath; Gernot Seppel; Stefan Hinterwimmer; Andreas B Imhoff; Peter U Brucker
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2014-06-15       Impact factor: 4.342

Review 4.  Systematic Review of Outcome Measures Used After Proximal Hamstring Repair.

Authors:  Tara Reza; Andrew J Hinkle; Andre Perez-Chaumont; Symone M Brown; Mary K Mulcahey
Journal:  Orthop J Sports Med       Date:  2021-05-07

5.  High-Grade Partial and Retracted (<2 cm) Proximal Hamstring Ruptures: Nonsurgical Treatment Revisited.

Authors:  Jonathan R Piposar; Amrit V Vinod; Joshua R Olsen; Edward Lacerte; Suzanne L Miller
Journal:  Orthop J Sports Med       Date:  2017-02-23

6.  Surgical Repair of Distal Biceps Femoris Avulsion Injuries in Professional Athletes.

Authors:  Joshua W Thompson; Ricci Plastow; Babar Kayani; Peter Moriarty; Ajay Asokan; Fares S Haddad
Journal:  Orthop J Sports Med       Date:  2021-03-26

7.  [Clinical results after refixation of proximal hamstring tendon ruptures comparing different anchor systems].

Authors:  M Irger; P Forkel; A B Imhoff; L Willinger
Journal:  Unfallchirurg       Date:  2021-06-18       Impact factor: 1.000

8.  Does Time From Injury to Surgery Affect Outcomes After Surgical Repair of Partial and Complete Proximal Hamstring Ruptures?

Authors:  Braidy C Shambaugh; Thomas H Wuerz; Suzanne L Miller
Journal:  Orthop J Sports Med       Date:  2020-08-28

9.  Bioinductive Collagen Implant Augmentation for the Repair of Chronic Lower Extremity Tendinopathies: A Report of Two Cases.

Authors:  Austin M Looney; Luc M Fortier; Joseph D Leider; Brandon J Bryant
Journal:  Cureus       Date:  2021-06-10

Review 10.  Tears of biceps femoris, semimembranosus, and semitendinosus are not equal-a new individual muscle-tendon concept in athletes.

Authors:  Lasse Lempainen; Jussi Kosola; Ricard Pruna; Juha-Jaakko Sinikumpu; Xavier Valle; Olli Heinonen; Sakari Orava; Nicola Maffulli
Journal:  Scand J Surg       Date:  2021-02-21       Impact factor: 2.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.